SEAVIEW ORTHOPAEDICS on
Assignment from FRANCES
FLEMING,
Plaintiff-Appellant,
v.
NATIONAL HEALTHCARE RESOURCES,
INC., d/b/a NHR, as third party
vendor/administrator for
ALLSTATE INDEMNITY COMPANY d/b/a
ALLSTATE and ALLSTATE INDEMNITY
COMPANY d/b/a ALLSTATE and
CONSUMER HEALTH NETWORK, d/b/a
CHN,
Defendants-Respondents.
________________________________________________________
Argued November 12, 2003 - Decided February 13, 2004
Before Judges Skillman, Coburn and Fisher.
On appeal from Superior Court of New Jersey, Law Division, Middlesex County, Special
Civil Part, Docket No. DC-010307-01.
Stephen A. Gravatt argued the cause for appellant (Mr. Gravatt, on the brief).
Curtis J. Turpan argued the cause for respondent, National Healthcare Resources (Harwood Lloyd,
LLC, attorneys; Mr. Turpan, of counsel and on the brief).
David J. Klinger argued the cause for respondent, Allstate Indemnity Company (Gutterman, Markowitz
& Klinger, attorneys; Frank W. Farrell, on the brief).
Thomas P. Weidner argued the cause for respondent, Consumer Health Network (Windels, Marx,
Lane & Mittendorf, attorneys; Mr. Weidner, of counsel; David F. Swerdlow and Jennifer
Stefanick, on the brief).
The opinion of the court was delivered by
FISHER, J.A.D.
Regardless of the type of insurance an individual . . . may have,
whether a traditional health indemnity policy, HMO coverage, Medicare, or an automobile insurance
policy, the patient should not be subject to unnecessary medical treatments or diagnostic
tests, or take advantage of overutilization. . . . Limiting medical treatments and
tests to those that are medically necessary does not necessarily create a dual
standard of medical care. Indeed, the legislative goal appears to be a single,
legitimate standard.
[N.J. Coalition of Health Care v. Dep't of Banking and Ins.,
323 N.J.
Super. 207, 248-49 (App. Div.) (emphasis added), certif. denied,
162 N.J. 485 (1999).]
In short, as Judge King said for the court in N.J. Coalition, the
no-fault laws do "not directly control or regulate medical practice per se but
regulate[] only the insurance compensation mechanism." Id. at 220. That plaintiffs may have
further limited their right to reimbursement for the services rendered to auto accident
victims by entering into the CHN contract does not violate the no-fault laws.
We view the essence of plaintiffs' argument to be their regret over having
entered into an agreement which contains, as one of its consequences, plaintiffs' agreement
to accept less reimbursement than authorized by the no-fault statutory scheme and the
applicable regulations for patients who are auto accident victims. Plaintiffs' displeasure over this
consequence, however, does not give rise to a legitimate claim that the agreement
is inconsistent with the no-fault statutory scheme. By agreeing to accept less from
insurers (and, in so doing, requiring patients to make lesser co-payments), the parties
to the CHN contract are providing a benefit to insurers and insureds which
actually serves, and not disserves, the goals of our no-fault statutory scheme.
A review of the history of the no-fault laws, already thoroughly canvassed by
Judge King in N.J. Coalition, supra, 323 N.J. Super. at 215-23, and which
we will only briefly summarize, demonstrates the lack of merit in plaintiffs' arguments
in this regard.
The primary reform of the New Jersey Automobile Reparation Reform Act of 1972,
L. 1972, c. 70, §4, was to mandate personal injury protection coverage payable
to an insured (and family members) for injuries sustained as a result of
an automobile accident without regard to "negligence, liability or fault of any kind"
of the insured (or family members). N.J.S.A. 39:6A-4. Its goal was to compensate
"a larger class of citizens than the traditional tort-based system and doing so
with greater efficiency at a lower cost." N.J. Coalition, supra, 323 N.J. Super.
at 216 (quoting Emmer v. Merin,
233 N.J. Super. 568, 572 (App. Div.),
certif. denied,
118 N.J. 181 (1989)). This innovation, however, "did not slow the
rise in automobile insurance premiums," and caused the Legislature to enact the New
Jersey Automobile Insurance Freedom of Choice and Cost Containment Act of 1984, L.
1983, c. 362, which "introduced the concept of tort options and choice between
two monetary thresholds for soft-tissue injuries." N.J. Coalition, supra, 323 N.J. Super. at
216. Notwithstanding these efforts, insurance premiums in New Jersey continued to rise and
retained a place among the highest in the United States. Id. at 216-17;
Emmer, supra, 233 N.J. Super. at 573.
As a result, the statutory scheme was amended in 1988, L. 1988, c.
119, and again with the adoption of the "Fair Automobile Insurance Reform Act
of 1990," L. 1990, c. 8. These were yet additional attempts "to achieve
premium reduction and economy in the no-fault system." N.J. Coalition, supra, 323 N.J.
Super. at 217 (citing Roig v. Kelsey,
135 N.J. 500, 509-10 (1994)). One
aspect of the Fair Automobile Insurance Reform Act of 1990 was its rewriting
of the fee schedule provisions contained in N.J.S.A. 39:6A-4.6 to
incorporate the reasonable and prevailing fees of 75% of the practitioners [within a
region and providing that] [n]o health care provider may demand or request any
payment from any person in excess of those permitted by the medical fee
schedules established pursuant to this section . . . .
[L. 1990, c. 8, §7 (emphasis added).]
Still, despite these legislative efforts, New Jersey consumers did not obtain an alleviation
from exorbitant insurance premiums.
In 1998, the Automobile Insurance Cost Reduction Act (AICRA), L. 1998, c. 21,
was signed into law, making further alterations to the no-fault statutory scheme. The
Legislature explained its intent at some length, including the following:
. . . Since the enactment of the verbal threshold in 1988, the
substantial increase in the cost of medical expense benefits indicates that the benefits
are being overutilized for the purpose of gaining standing to sue for pain
and suffering, thus undermining the limitations imposed by the threshold and necessitating the
imposition of further controls on the use of those benefits, . . .
. . . .
. . . To meet these goals, this legislation . . . provides
for cost containment of medical expense benefits through a revised dispute resolution proceeding,
provides for a revised lawsuit threshold for suits for pain and suffering which
will eliminate suits for injuries which are not serious or permanent, . .
. and establishes standard treatment and diagnostic procedures against which the medical necessity
of treatments reimbursable under medical expense benefits coverage would be judged.
. . . .
. . . With these many objectives, the Legislature nevertheless requires that to
provide a healthy and competitive automobile insurance market, insurers are entitled to earn
an adequate rate of return through the ratemaking process, which shall reflect the
impact of the cost-saving provisions of this act and other recent legislative insurance
reforms; and
. . . The Legislature has thus addressed these and other issues in
this comprehensive legislation designed to preserve the no-fault system, while at the same
time reducing unnecessary costs which drive premiums higher.
[N.J.S.A. 39:6A-1.1 (emphasis added).]
In summary, the principle purposes driving the existing no-fault laws and its prior
incarnations are the preservation of the no-fault system, coupled with the limitation or
elimination of unnecessary or minor personal injury claims, and the containment of medical
costs and expenses which have driven premiums to exorbitant rates in New Jersey.
N.J. Coalition, supra, 323 N.J. Super. at 218, 239, 248-49.
In particular, the need to contain medical expenses and its important role in
the creation of our no-fault laws informs our decision in the case at
hand. As observed in N.J. Coalition, "New Jersey has been ranked first nationally
in average cost of care for automobile accident injuries, duration of treatment, and
number of provider visits." Id. at 239 (citing
30 N.J.R. 3211); see also
N.J.S.A. 39:6A-1.1 ("It is generally recognized that," among other things, "inappropriate medical treatments
. . . ha[ve] increased insurance premiums."). Each step taken by our Legislature
in amending the no-fault laws was intended to address cost containment. See Coalition
for Quality Health Care v. Dep't of Banking and Ins.,
348 N.J. Super. 272, 308-09 (App. Div.) (where N.J.A.C. 11:3-4.8, which authorizes insurers to encourage the
use of certain vendors for diagnostic testing by imposing co-payments (up to 50%
of the cost of the service) on an insured that goes outside the
network, was upheld because the regulation is "consistent with AICRA's cost containment goals"),
certif. denied,
174 N.J. 194 (2002); N.J. Coalition, supra, 323 N.J. Super. at
247 ("The physicians' understandable preference for reimbursement for treatment and services without regard
to inhibiting standards or guideline constraints is fundamentally and irreconcilably in conflict with
AICRA's mandate.").
So viewed, plaintiffs' argument that the CHN contract should not be enforced because
it requires them to accept less than their customary rates and less than
permitted by the PIP fee schedule, is fundamentally unsound. Plaintiffs' argument is faulty
because enforcing their consensual agreement with CHN to accept lesser rates has the
salutary effect of causing lower payments to be made by insurers and, a
fortiori, lesser co-payments from insureds.
See footnote 7 This consequence is completely consistent with the Legislature's
numerous and prodigious efforts in this area:
The high costs associated with such alarming figures is initially borne by the
State's automobile insurance system and ultimately passed on to the State's consumers. In
enacting AICRA, the Legislature was determined to change this situation and to make
insurance more affordable.
[
Id. at 239.]
We also reject plaintiffs' contention that because PPO agreements are not mentioned in
the no-fault statutory scheme, the Legislature intended not to authorize -- and we
should not enforce -- such agreements. We see nothing in the no-fault statutory
scheme which would suggest the Legislature's antagonism toward any agreement which would have
the effect of further reducing the burdens of insurers and insureds. To determine
the legitimacy of CHN's rate schedule for auto accident victims, we should not
assume the Legislature, through silence, impliedly determined to foreclose their enforcement. Instead, we
should consider the purposes of the statutory scheme to determine whether such agreements
are permitted.
The legislative purpose of containing medical costs by way of care paths and
fee schedules was not to require the payment of costs pursuant to those
schedules in all instances. Instead, the Legislature intended only to erect a ceiling
as to what is reimbursable to providers. See Thermo. Diagnostics, Inc. v. Allstate
Ins. Co.,
125 N.J. 491, 518 (1991) ("[T]he fee schedules promulgated by the
Commissioner of Insurance establish maximum fees for a variety of diagnostic-imaging techniques."); Cobo
v. Market Transition Facility,
293 N.J. Super. 374, 384 (App. Div. 1996) (N.J.S.A.
39:6A-4.6 "explicitly establishes the fee schedule rates as a ceiling on reimbursable costs.").
A voluntary agreement between a provider and an entity such as CHN, which
has the effect of lowering that ceiling, does not run counter to the
purposes of the no-fault statutory scheme but, rather, further fulfills its goals.
In seeking to demonstrate that the CHN contract is contrary to public policy,
plaintiffs lastly argue that section 5.2.5 of the CHN contract violates the no-fault
law's policy in favor of arbitration, N.J.S.A. 39:6A-1.1, by inhibiting their right to
arbitrate. We reject this contention as well. Section 5.2.5 contains plaintiffs' "waive[r] [of]
any amounts from any Payor and any Eligible Person (i) in excess of
the fees customarily charged to other patients or the amounts provided in the
[CHN] Fee Schedule; and (ii) any amount from any Payor or Eligible Person
for services performed which have been deemed not to be Medically Appropriate by
the Utilization Management Program." There is nothing in the language of this provision
which would suggest that a provider may be prohibited from seeking arbitration of
a dispute. Undoubtedly the existence of the CHN contract would render pointless the
arbitration of disputes as to what reimbursement would be permitted in accordance with
the PIP fee schedule. And it is also true, as defendants contend, that
any arbitration award would ultimately be subject to the fee schedule and any
other limitations on reimbursement contained in the CHN contract. But there is no
evidence in the record to suggest that any of these parties has attempted
to avoid PIP arbitration because of the terms of the CHN contract and,
to the extent that PIP arbitration among these parties might be appropriate in
a given circumstance, there is nothing in the CHN contract which would bar
such a proceeding. Accordingly, we conclude that the premise upon which this particular
argument is based is faulty, and we need not further consider whether some
limitation or even elimination of a provider's right to arbitrate would compel a
holding that the contract, in all other respects, not be enforced -- a
result we view as unlikely.
See footnote 8
For all these reasons, we conclude that a PPO agreement, such as that
in question, is entirely compatible with the no-fault scheme because such contracts do
not increase but, rather, tend to lessen the monetary obligations of insurers and
insureds, a consequence which meets with the legislative intent of containing medical costs,
lowering insurance premiums and benefiting New Jersey's consumers. As a result, we reject
plaintiffs' contentions in their entirety and affirm the entry of summary judgment dismissing
the complaints in these forty actions. We will also affirm the order imposing
costs in favor of defendants and against plaintiffs in each action.
Footnote: 1This appeal seeks our review of orders granting summary judgment in favor of
defendants in the above-captioned matter and thirty-nine other suits. We previously granted plaintiffs
permission to file one appeal for all forty cases.
Footnote: 2Section 2.1 of the contract states: "'Plans' means individual and group health benefit
contracts, workers compensation programs, policies of health insurance,
policies of automobile insurance, health
maintenance organization programs or other plans of a Payor which shall be subject
to this Agreement" (emphasis added).
Footnote: 3
Section 5.2.5 of the contract states: "Provider shall accept as full payment from
each Payor for the Covered Services deemed Medically Appropriate pursuant to the Utilization
Management Program the lesser of charges customarily charged to other patients or the
consideration provided in the Fee Schedule. Provider hereby waives any amounts from any
Payor and any Eligible Person (i) in excess of the fees customarily charged
to other patients or the amounts provided in the Fee Schedule; and (ii)
any amount from any Payor or Eligible Person for services performed which have
been deemed not to be Medically Appropriate by the Utilization Management Program."
Footnote: 4Section 3.1.1 of the contract states: "Provider accepts and is hereby bound by
the Standard Terms and the Fee Schedule and shall be bound by any
other fee schedule negotiated or renegotiated by CHN, directly or indirectly, with a
Payor."
See also Section 5.2.5 set forth in footnote 3, supra.
Footnote: 5
There is no evidence in the record to demonstrate that this aspect of
the CHN contract provides CHN with "windfall" profits but we will assume, for
purposes of the matter before us, that plaintiffs' claim in this regard is
factually accurate.
Footnote: 6Section 8.1 of the contract states: "Nothing contained in this Agreement shall interfere
with or in any way alter any provider-patient relationship and Provider shall have
the sole responsibility for the care and treatment of Eligible Persons under Provider's
care. Nothing contained herein shall grant CHN or any party performing utilization management
the right to govern the level of care of a patient. Utilization management
decisions shall only effect reimbursement of Provider for services rendered and shall not
limit the performance of the services of Provider or effect Provider's professional judgment."
Footnote: 7It also has a beneficial impact on the available PIP dollars for each
insured. For example, if an insured's PIP coverage had a limit of $15,000,
and a provider's non-contract rate for a medical procedure was $1000, an insured
would have, after that payment, $14,000 in available PIP benefits remaining. However, if,
as here, the provider agreed to accept less for the same treatment --
for example, $500 -- then the insured would have $14,500 in available PIP
benefits remaining. As a result of the provider's agreement to accept less, the
insured realizes a financial benefit in retaining a higher amount of remaining coverage.
Footnote: 8We observe that the parties to the CHN contract also agreed in section
8.12 that if any of its provisions are found to be "invalid or
unenforceable . . . the remaining portion or portions shall nevertheless be valid,
enforceable and of full force and effect."